1. Skeletal muscle atrophy: Potential therapeutic agents and their mechanisms of action
    Vikas Dutt et al, 2015, Pharmacological Research CrossRef
  2. Formoterol attenuates increased oxidative stress and myosin protein loss in respiratory and limb muscles of cancer cachectic rats
    Anna Salazar-Degracia et al, 2017, PeerJ CrossRef
  3. The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats
    Mareike S. Pötsch et al, 2014, Journal of Cachexia, Sarcopenia and Muscle CrossRef
  4. Counteracting Muscle Atrophy on Earth and in Space via Nanofluidics Delivery of Formoterol
    Andrea Ballerini et al, 2020, Advanced Therapeutics CrossRef
  5. Beta2-Agonist Doping Control and Optical Isomer Challenges
    Glenn A. Jacobson et al, 2016, Sports Medicine CrossRef
  6. Cardiac cachexia: hic et nunc
    Goran Loncar et al, 2016, Journal of Cachexia, Sarcopenia and Muscle CrossRef
  7. The role of exercise-induced myokines in regulating metabolism
    Joo Young Huh, 2018, Archives of Pharmacal Research CrossRef
  8. New insights on the regulation of cancer cachexia by N-3 polyunsaturated fatty acids
    Renata Gorjao et al, 2019, Pharmacology & Therapeutics CrossRef
  9. β2-Adrenergic agonist salbutamol augments hypertrophy in MHCIIa fibers and sprint mean power output but not muscle force during 11 weeks of resistance training in young men
    Søren Jessen et al, 2021, Journal of Applied Physiology CrossRef
  10. Myostatin — From the Mighty Mouse to cardiovascular disease and cachexia
    Thomas Bernd Dschietzig, 2014, Clinica Chimica Acta CrossRef
  11. Mechanisms underlying enhancements in muscle force and power output during maximal cycle ergometer exercise induced by chronic β2-adrenergic stimulation in men
    Morten Hostrup et al, 2015, Journal of Applied Physiology CrossRef
  12. Mitochondrial dynamics in cancer-induced cachexia
    Miranda van der Ende et al, 2018, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  13. Muscle wasting: an overview of recent developments in basic research
    Sandra Palus et al, 2014, Journal of Cachexia, Sarcopenia and Muscle CrossRef
  14. Muscle Wasting Diseases: Novel Targets and Treatments
    Regula Furrer et al, 2019, Annual Review of Pharmacology and Toxicology CrossRef
  15. Effects of the beta 2 agonist formoterol on atrophy signaling, autophagy, and muscle phenotype in respiratory and limb muscles of rats with cancer-induced cachexia
    Anna Salazar-Degracia et al, 2018, Biochimie CrossRef
  16. β2-Adrenergic agonists and the treatment of skeletal muscle wasting disorders
    Olivier R. Joassard et al, 2013, The International Journal of Biochemistry & Cell Biology CrossRef
  17. Skeletal Muscle Deconditioning in Breast Cancer Patients Undergoing Chemotherapy: Current Knowledge and Insights From Other Cancers
    Joris Mallard et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  18. Drugs for the Treatment of Muscle Atrophy
    Linlin Chen et al, 2021, Background and Management of Muscular Atrophy CrossRef
  19. Differential structural features in soleus and gastrocnemius of carnitine‐treated cancer cachectic rats
    Sílvia Busquets et al, 2020, Journal of Cellular Physiology CrossRef
  20. Anabolic and lipolytic actions of beta 2 ‐agonists in humans and antidoping challenges
    Morten Hostrup et al, 2020, Drug Testing and Analysis CrossRef
  21. Muscle wasting: An overview of recent developments in basic research
    Sandra Palus et al, 2014, International Journal of Cardiology CrossRef
  22. Cancer-Associated Cachexia: A Systemic Consequence of Cancer Progression
    Anup K. Biswas et al, 2020, Annual Review of Cancer Biology CrossRef
  23. Cardiac cachexia: hic et nunc
    Goran Loncar et al, 2015, International Journal of Cardiology CrossRef
  24. Polyphenols and Their Effects on Muscle Atrophy and Muscle Health
    Takeshi Nikawa et al, 2021, Molecules CrossRef
  25. A differential pattern of gene expression in skeletal muscle of tumor-bearing rats reveals dysregulation of excitation-contraction coupling together with additional muscle alterations
    Cibely Cristine Fontes-Oliveira et al, 2014, Muscle & Nerve CrossRef
  26. Formoterol decreases muscle wasting as well as inflammation in the rat model of rheumatoid arthritis
    Ana Belén Gómez-SanMiguel et al, 2016, American Journal of Physiology-Endocrinology and Metabolism CrossRef